Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Influenza Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
AstraZeneca
Seqirus
Roche
Bayer
Sanofi Pasteur
Celgene
Novartis
Protein Sciences Corporation
Serum Institute of India
GlaxoSmithKline
Emergent Biosolutions
Alvogen
Bristol-Myers Squibb]
By Type:
Other Influenza Drugs
Peramivir
Zanamivir
Oseltamivir Phosphate
By Application:
Chidren
Adults
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Influenza Drugs Market Overview 2018-2029
-
1.1 China Influenza Drugs Industry Development Overview
-
1.2 China Influenza Drugs Industry Development History
-
1.3 China Influenza Drugs Industry Market Size (2018-2029)
-
1.4 China Influenza Drugs Market Analysis by Type from Production Side
-
1.4.1 China Influenza Drugs Production Volume, Production Value and Growth Rate of Other Influenza Drugs (2018-2029)
-
1.4.2 China Influenza Drugs Production Volume, Production Value and Growth Rate of Peramivir (2018-2029)
-
1.4.3 China Influenza Drugs Production Volume, Production Value and Growth Rate of Zanamivir (2018-2029)
-
1.4.4 China Influenza Drugs Production Volume, Production Value and Growth Rate of Oseltamivir Phosphate (2018-2029)
-
1.5 China Influenza Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Influenza Drugs Sales Volume, Sales Value and Growth Rate of Chidren (2018-2029)
-
1.5.2 China Influenza Drugs Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)
-
1.6 China Influenza Drugs Market Analysis by Region
-
1.6.1 North China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Influenza Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Influenza Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Influenza Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Influenza Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Influenza Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Influenza Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Influenza Drugs Industry Development
Chapter 3 Influenza DrugsIndustry Chain Analysis
-
3.1 Influenza Drugs Industry Chain
-
3.2 Influenza Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Influenza Drugs Market
-
3.3 Influenza Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Influenza Drugs Market
Chapter 4 China Influenza Drugs Market, by Type
-
4.1 China Influenza Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Influenza Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Influenza Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Influenza Drugs Production Volume and Growth Rate of Other Influenza Drugs
-
4.5.2 China Influenza Drugs Production Volume and Growth Rate of Peramivir
-
4.5.3 China Influenza Drugs Production Volume and Growth Rate of Zanamivir
-
4.5.4 China Influenza Drugs Production Volume and Growth Rate of Oseltamivir Phosphate
Chapter 5 China Influenza Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Influenza Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Influenza Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Influenza Drugs Market Size and Growth Rate of Chidren
-
5.5.2 China Influenza Drugs Market Size and Growth Rate of Adults
Chapter 6 China Influenza Drugs Market, by Region
-
6.1 China Influenza Drugs Production Volume and Production Value, by Region
-
6.2 China Influenza Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Influenza Drugs Market Analysis
-
7.1 North China Influenza Drugs Market, by Type
-
7.2 North China Influenza Drugs Market, by Application
Chapter 8 Central China Influenza Drugs Market Analysis
-
8.1 Central China Influenza Drugs Market, by Type
-
8.2 Central China Influenza Drugs Market, by Application
Chapter 9 South China Influenza Drugs Market Analysis
-
9.1 South China Influenza Drugs Market, by Type
-
9.2 South China Influenza Drugs Market, by Application
Chapter 10 East China Influenza Drugs Market Analysis
-
10.1 East China Influenza Drugs Market, by Type
-
10.2 East China Influenza Drugs Market, by Application
Chapter 11 Northeast China Influenza Drugs Market Analysis
-
11.1 Northeast China Influenza Drugs Market, by Type
-
11.2 Northeast China Influenza Drugs Market, by Application
Chapter 12 Southwest China Influenza Drugs Market Analysis
-
12.1 Southwest China Influenza Drugs Market, by Type
-
12.2 Southwest China Influenza Drugs Market, by Application
Chapter 13 Northwest China Influenza Drugs Market Analysis
-
13.1 Northwest China Influenza Drugs Market, by Type
-
13.2 Northwest China Influenza Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Profile
-
14.1.2 AstraZeneca Influenza Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Seqirus
-
14.2.1 Seqirus Company Profile
-
14.2.2 Seqirus Influenza Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Roche
-
14.3.1 Roche Company Profile
-
14.3.2 Roche Influenza Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Bayer
-
14.4.1 Bayer Company Profile
-
14.4.2 Bayer Influenza Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Sanofi Pasteur
-
14.5.1 Sanofi Pasteur Company Profile
-
14.5.2 Sanofi Pasteur Influenza Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Celgene
-
14.6.1 Celgene Company Profile
-
14.6.2 Celgene Influenza Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Novartis
-
14.7.1 Novartis Company Profile
-
14.7.2 Novartis Influenza Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Protein Sciences Corporation
-
14.8.1 Protein Sciences Corporation Company Profile
-
14.8.2 Protein Sciences Corporation Influenza Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Serum Institute of India
-
14.9.1 Serum Institute of India Company Profile
-
14.9.2 Serum Institute of India Influenza Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 GlaxoSmithKline
-
14.10.1 GlaxoSmithKline Company Profile
-
14.10.2 GlaxoSmithKline Influenza Drugs Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Emergent Biosolutions
-
14.11.1 Emergent Biosolutions Company Profile
-
14.11.2 Emergent Biosolutions Influenza Drugs Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Alvogen
-
14.12.1 Alvogen Company Profile
-
14.12.2 Alvogen Influenza Drugs Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Bristol-Myers Squibb]
-
14.13.1 Bristol-Myers Squibb] Company Profile
-
14.13.2 Bristol-Myers Squibb] Influenza Drugs Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Influenza Drugs Industry Research Conclusions
-
15.2 Influenza Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Influenza Drugs Industry Market Size (2018-2029)
-
Figure China Influenza Drugs Production Volume, Production Value and Growth Rate of Other Influenza Drugs (2018-2029)
-
Figure China Influenza Drugs Production Volume, Production Value and Growth Rate of Peramivir (2018-2029)
-
Figure China Influenza Drugs Production Volume, Production Value and Growth Rate of Zanamivir (2018-2029)
-
Figure China Influenza Drugs Production Volume, Production Value and Growth Rate of Oseltamivir Phosphate (2018-2029)
-
Figure China Influenza Drugs Sales Volume, Sales Value and Growth Rate of Chidren (2018-2029)
-
Figure China Influenza Drugs Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)
-
Figure North China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Influenza Drugs Market Size and Growth Rate from 2018-2029
-
Figure Influenza Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Influenza Drugs Market Share by Type in 2018
-
Figure China Influenza Drugs Market Share by Type in 2023
-
Figure China Influenza Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Influenza Drugs Production Volume and Growth Rate of Other Influenza Drugs (2018-2023)
-
Figure China Influenza Drugs Production Volume and Growth Rate of Peramivir (2018-2023)
-
Figure China Influenza Drugs Production Volume and Growth Rate of Zanamivir (2018-2023)
-
Figure China Influenza Drugs Production Volume and Growth Rate of Oseltamivir Phosphate (2018-2023)
-
Figure China Influenza Drugs Market Share by Application in 2018
-
Figure China Influenza Drugs Market Share by Application in 2023
-
Figure China Influenza Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Influenza Drugs Market Size and Growth Rate of Chidren (2018-2023)
-
Figure China Influenza Drugs Market Size and Growth Rate of Adults (2018-2023)
-
Table China Influenza Drugs Production Volume by Region (2018-2023)
-
Table China Influenza Drugs Production Volume Share by Region (2018-2023)
-
Figure China Influenza Drugs Production Volume Share by Region (2018-2023)
-
Table China Influenza Drugs Production Value by Region (2018-2023)
-
Table China Influenza Drugs Production Value Share by Region (2018-2023)
-
Figure China Influenza Drugs Production Value Share by Region (2018-2023)
-
Table China Influenza Drugs Sales Volume by Region (2018-2023)
-
Table China Influenza Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Influenza Drugs Sales Volume Share by Region (2018-2023)
-
Table China Influenza Drugs Sales Value by Region (2018-2023)
-
Table China Influenza Drugs Sales Value Share by Region (2018-2023)
-
Figure China Influenza Drugs Sales Value Share by Region (2018-2023)
-
Table North China Influenza Drugs Production Volume by Type (2018-2023)
-
Table North China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Table North China Influenza Drugs Sales Volume by Application (2018-2023)
-
Table North China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Influenza Drugs Production Volume by Type (2018-2023)
-
Table Central China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Influenza Drugs Sales Volume by Application (2018-2023)
-
Table Central China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Influenza Drugs Production Volume by Type (2018-2023)
-
Table South China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Table South China Influenza Drugs Sales Volume by Application (2018-2023)
-
Table South China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Influenza Drugs Production Volume by Type (2018-2023)
-
Table East China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Table East China Influenza Drugs Sales Volume by Application (2018-2023)
-
Table East China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Influenza Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Influenza Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Influenza Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Influenza Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Influenza Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Influenza Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Influenza Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Influenza Drugs Sales Volume Share by Application (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Seqirus Company Profile
-
Table Seqirus Influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Sanofi Pasteur Company Profile
-
Table Sanofi Pasteur Influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Celgene Company Profile
-
Table Celgene Influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Protein Sciences Corporation Company Profile
-
Table Protein Sciences Corporation Influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Serum Institute of India Company Profile
-
Table Serum Institute of India Influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Emergent Biosolutions Company Profile
-
Table Emergent Biosolutions Influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Alvogen Company Profile
-
Table Alvogen Influenza Drugs Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb] Company Profile
-
Table Bristol-Myers Squibb] Influenza Drugs Revenue, Price and Gross (2018-2023)
-
